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Scientific and technological advances will never be anti-ethical. For mankind, “a search for new ways” means better conditions
for achieving autonomy. Everything that has been discovered in the last few decades, from how to control the birth rate, to the recent
probability of being able to clone human beings, and, within these latest discoveries, the extraordinary possibility of manipulating
the human gene itself, empowers us to assume control of what until now was unknown, and thus we will be able to attain a better
quality of life.
With respect to the ideal, it is unquestionable that the knowledge that could substantially change our lives on this planet should
be within reach of the world society; society itself should be responsible for monitoring the applications of this knowledge.
The present article discusses the ethics and the patenting of the human genome, arguments for and against gene patenting,
patents and research into human embryos, legal aspects, and intellectual property in the field of the human genome.
DESCRIPTORS: Bioethics. Genomics. Human Rights. Patenting. Intellectual Property.
Scientific and technological ad-
vances will never be anti-ethical. For
mankind, “a search for new ways”
means better conditions for achieving
autonomy. Everything that has been
discovered in the last few decades,
from how to control the birth rate, to
the recent probability of being able to
clone human beings, and, within these
latest discoveries, the extraordinary
possibility of manipulating the human
gene itself, empowers us to assume
control of what until now, was un-
known, and thus we will be able to at-
tain a better quality of life.
The fear, which is understandable,
regarding what is going to happen the
moment we modify our habitat and
ourselves is founded on the fear of the
unknown. We live with tragedies, such
as wars, oppressions, inequalities of
every type, affronts to human dignity
at all levels, diseases, etc., but the mo-
ment we are told “Man is playing of
God”, many of us belittle ourselves
without debating the issue. We forget
that man has played this game for all
of recorded history, and that if it were
not for this game, we would not have
won the battle against so many dis-
eases—a victory that has prolonged
life expectation for decades, reduced
infant mortality, etc .
What could be frightening is the
way in which we apply the new knowl-
edge, which could be used for dis-
crimination, oppression, and extermi-
nation, as so many other advances in
knowledge have been used. It could be
said to those who condemn and abhor
the discovery of nuclear energy that,
considered on its own merit, this ad-
vancement in knowledge was an enor-
mous success for science; what we
condemn was its use in killing millions
of human beings. We must remember
that a treaty of non-proliferation of
nuclear weapons was drawn up and
signed and that, up to the present time,
it has been respected; therefore, it is
clear that we are (or, if not, should be),
capable of responsibly administering
the application of new techniques with
the intent of applying them in ways
that are compatible to our sense of eth-
ics. Therefore, since we accept that
knowledge will never be ethical or
anti-ethical a priori, we will not raise
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objections to the freedom of develop-
ing this new knowledge.
It is an ideal (utopian, while at the
same time ideal) that knowledge that
could substantially change our lives on
this planet—and change the planet it-
self—should be totally acceptable to
the world society; society itself should
be responsible for monitoring the ap-
plications of this knowledge. We can
say that through the branch of the
United Nations Organization (UNO),
which is directed to health and educa-
tion (United Nations Educational, Sci-
entific and Cultural Organization -
UNESCO), world society embraces
this ideal—at least in theory.
The acceptance or not of patenting
knowledge, the experimental applica-
tion of this knowledge, the application
of new techniques on a wider scale, or
the question as who might develop
these techniques (private enterprises,
government enterprises, or others)1 is
something that must be discussed. It is
perfectly understandable, for example,
to accept that a certain laboratory may
patent its research (at least for a finite
period) as long as the patent does not
impede other research laboratories
from applying the techniques resulting
from these studies towards applications
that might benefit humanity.
ARGUMENTS FOR AND
AGAINST GENE PATENTS
The question of gene patenting in-
volves several different fields (eco-
nomic, philosophical, religious, etc.),
and as a result, a varied number of ar-
guments with respect to it arise. Some
of these arguments are presented here.
Among those who defend gene pat-
ents are those who wish to offer a re-
ward to the researcher, who, like other
workers, should be able to reap the
benefits of their work. Thus, in return
for the time, energy, and resources
spent on their work, a patent should be
given in compensation. The argument
against this position is that after con-
sidering the market value of these pat-
ents, it is reasonable to conclude that
they provide a much greater benefit
than the owner deserves. The majority
of innovations can be attributed to the
scientific predecessors of biotechnolo-
gists, such as Darwin and Mendel. To
say that a researcher is responsible for
the total value of the organism or gene
modified is like saying that the last per-
son called to help lift up a car should
receive all the credit for lifting it.
Moreover, it should not be forgot-
ten that a large part of biological re-
search that eventually leads to the dis-
tribution of private patents is financed
by public resources. It is common
knowledge that every inventor needs to
use natural products and pre-existing
components, and at the same time it is
very clear that all inventors rely on
their predecessors. One of the most
common arguments in favor of
biopatents is their great social utility,
which surpasses any other consider-
ation. Biopatents serve as a necessary
incentive to encourage and support in-
novations. Without them, competitors
would prefer to let others innovate, so
they can copy the final product and sell
it for a lower price than the innovator
can, since they would not have to pay
the cost of research and development.
A possible argument against pat-
ents is that the process of transferring
biological knowledge into private
knowledge threatens the continuance
of scientific cooperation, and slows
down the rate of innovations. More-
over, businesses uniting universities
and industries result in secrecy in uni-
versity laboratories and a growing
amount of skepticism in relation to the
value of exchanging information
among colleagues. The counter argu-
ment is that patents do not hinder pure
scientific research, since any scientific
use of the invention patented does not
constitute a violation of the patent.
Apart from this, experience has proved
that an effective transfer of technology
from laboratories to industries can only
be done by way of an active and effec-
tive policy of patenting and licensing.
Contrary to the argument for con-
fidentiality of research, it can be
pointed out that upon submitting appli-
cations for patenting (at least in Eu-
rope), secrecy is not guaranteed. On
the contrary, by submitting these appli-
cations, an immediate publication of
the invention is permitted. In addition,
it should not be forgotten that a com-
mon practice among scientists in this
area is of not sharing the results of their
research until their papers have been
published (this is not so very different
from the practice of patenting).
Another argument in favor of pat-
ents is that if they were abolished,
people would seek other ways to pro-
tect their innovations, resulting in the
keeping of commercial secrets, which,
in relation to accessing information, is
much worse than patenting. Applica-
tions for patents demand the revelation
of the technology involved, while the
protection of industrial secrets does not
require this disclosure.
Among those against patenting,
there are those who argue that patents
impede progress: they serve as incen-
tives for firms to invest resources in the
development and protection of pat-
ents—resources that could be used in
investments for inventions and innova-
tions. Additionally, they argue, the ex-
istence of patents could result in the
elimination of competition in the in-
dustrial field. Opponents of patents ar-
gue that biopatents pose a moral dan-
ger; they support social politics that
continues to encourage the human tra-
dition of domination, decision-making,
and manipulation of nature instead of
helping the population become equal
members and citizens of the planet.
In discussing the question of bio-
patents, it is also important to consider
the potential ecological damage that
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could appear as a result of the introduc-
tion of artificial genes into the environ-
ment. For example, by producing
plants resistant to chemical pest con-
trols, a new and dangerous dimension
is introduced into the ecological system
that could change the balance of nature
and damage the fertility of the soil.
However, these misgivings tend not to
overshadow the clear advantages of
biotechnology, nor do they warrant the
rejection of the idea of patenting genes.
Another point to be considered
concerns biological colonialism. By
assuming that human tissue is a natu-
ral resource, like iron and oil, research-
ers could look for “exotic” genes from
remote civilizations—genes that could
serve as raw material for a new and lu-
crative type of medical practice. This
practice could result in exploitation of
indigenous races—which are consid-
ered primitive by the western world—
without giving them any part of the
profits. This practice would amount to
exploitation of developing countries
(abundant sources of genetic resources)
by developed countries.
Another aspect for consideration is
the patenting of genetically modified
plants and animals. One of the prob-
lems in this context is: what is the to-
tal number of human genes that would
have to be “transplanted” to an animal
for it to be considered “human” or ani-
mal genes to a human for it to be con-
sidered an “animal”? In view of the
fact that today patents are given for ge-
netically modified animals that carry
human genes, will patenting of human-
animal hybrids be permitted? Here the
fear of creating genetically modified
monsters arises. Thus opponents of
biopatents argue that scientists should
not be encouraged by the system of
patenting to create half-human beings.
Elitist ideas have been related to
genetic research, inevitably raising is-
sues such as racism, due mainly to the
fact that historically some geneticists
believed that characteristics such as in-
telligence and integrity were connected
to the genetic structure, which conse-
quently determined the social status of
man. The role of “playing God” pro-
duces the danger of treating animals
and human beings as simply tools for
research. In addition, if one considers
the argument of the “snowball” effect,
as soon as the knowledge of how to
control and manipulate human re-
sponses and to create human hybrids
exists, there is the risk that experiments
without any scientific value will be per-
formed. However, by being taken to
the extreme, this argument ignores the
fact that there is strict government su-
pervision and control, prohibiting cru-
elty and limiting experiments.
Following are some other consider-
ations relating to the issue:
Arguments in favor of patenting:
- Genetic patenting is only a logi-
cal extension of the traditional use of
patents and does not represent great
changes (Raines).
- One should comprehend patenting
of animal and human genes in its cor-
rect historical and economical context.
Thus, as man has always dominated
the animal kingdom (selling and buy-
ing animals and raising animals in the
home); patenting their genetic material
is part of the process (Raines).
- There exists the natural right for
man to be recompensed for the fruits
of his labor, an argument used in favor
of property rights in general, and de-
rived from the theory of John Locke,
which originally stated: “I made it, I
created it, it is mine; it would not exist
without me.”
- Live organisms such as plants and
microorganisms do not have moral in-
terests that need to be taken into ac-
count ( Joel Finberg).
- Genes, cells, and other parts of the
organisms are artefacts in relation to
live organisms; therefore, there should
not be any conceptual difficulties in re-
lation to them, since they are not in-
volved in moral questions
(Schonmann).
- Any alteration, isolation, or puri-
fication of a substance or organism
from their natural state transforms
them into something else that is not
“found in nature,” and therefore is pat-
entable (in the USA genes are patent-
able when isolated and inserted with
other DNA into a cell) (Schonmann).
Arguments against patenting:
- It is irrational for society to guar-
antee the right of monopolizing some-
thing that everybody could use
(Hettinger).
- Patents and their market value are
a social phenomenon created by the ju-
dicial system and also by mechanisms
of supply and demand. The researcher
did not invent the gene that is to be pat-
ented, nor did he generate its market
value; hence, he does not have a natu-
ral right over it (Schonmann).
- Any mixture of something from
one person with something that is not
from that person does not mean that
the person is the “owner” of the mix-
ture. For example, a DNA molecule in-
jected into another organism (Robert
Nozick).
- Biocentrism theory: All creatures
possess moral interests that need to be
considered and respected. Always,
when determining what people can do
with organisms one should consider
the moral aspect, and take into consid-
eration the interest of the organism to
be obtained, even though it has been
raised by man or genetically manipu-
lated (Albert Schweizer).
- The patenting of genetic material
creates a fixed and distorted moral per-
ception with respect to our relationship
with organisms, which inevitably leads
to a depreciation of the value of life.
- All creatures that can feel pleasure
and pain have moral interests to be
considered; therefore, genetically al-
tered animals should not be treated as
mere research objects (Peter Singer).
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- The relation between genes and
the different organisms in which they
have been inserted is inseparable. The
genetic manipulations that are carried
out in an organism depend on the or-
ganism, and consequently its moral
questions (Schonmann).
- Genetic material contains 3.5 bil-
lion years of information relating to
human evolution, which lead to a de-
veloped life form, therefore the genetic
information belongs to everybody as
an inheritance and cannot be patented
(Hettinger).
- Genes were created naturally and
are not human inventions; they are only
discovered by research and are not pat-
entable (Hettinger).
PATENTS AND EMBRYONIC
RESEARCH
Cloned human embryos do not
have legal personalities, and at least in
theory, are viewed as cloned cellular
strains. Thus, could an embryo be clas-
sified within the legal prerequisites for
patenting, and as such be patented, re-
produced, and sold? A preliminary
question would be: Should scientific
research with human embryos be per-
mitted and could animal models serve
as substitutes? There are those who de-
fend the analysis of embryonic genetic
expression and its standards in order to
understand human development. The
legal personality of embryos must be
debated, since society today has no ac-
cepted definitions with respect to the
moral and legal status of frozen em-
bryos.
On the one hand, a human embryo
is a powerful symbol of humanity that
must be respected. On the other hand,
experiments with embryos would ben-
efit millions of people. Thought should
be given as to whether human dignity
is maintained in the process of produc-
ing genetically predetermined babies.
Embryos are actually potential people
and must receive the highest moral
valuation; any attempt to consider them
patentable would be an insult and mor-
ally questionable. But, on the other
hand, any embryo outside of the uterus
is not a potential person, just as an
ovum and a spermatozoon are not po-
tential people, because they are inca-
pable of developing alone. However, as
their development progresses and they
become more and more similar to an
entity that possesses moral status, they
stimulate our wish to protect them.
The patenting of genes is both an
ethical and a moral problem. Intu-
itively, many people reject the practice
of genetic experiments on animals and
humans (even more so the patenting of
them), but when analyzing this ques-
tion in a more realistic way, we must
remember that at least some genetic
techniques have been developed and
established and have not raised any
great objections.
The language of the different patent
laws has originated from inventions in
physics and chemistry, and maybe it
would be preferable to create a system
of protection more compatible with
biological inventions. On verifying
biopatents, it seems that intellectual
property rights are implicated; how-
ever, there is still a great deal of con-
fusion as to whether or not genes are
property and to whom they belong.
These questions can no longer be ig-
nored.
None of the arguments prevail over
the rest, especially when some have
mystical-religious bases that cannot be
refuted. This subject also involves not
only rational explanations but also
emotional ones, which leads to compli-
cations. It is important to emphasize
that even if patenting genes is allowed,
doing whatever one wants to is not per-
mitted. A patent by definition implies
what could be thought of as a “ nega-
tive” right, meaning the exclusion of
others from using the patent. Addi-
tional restrictions relating to the person
applying for a patent would be inter-
esting, especially in cases of possible
lethal or suicidal genes.
The progress and development of
scientific research requires a flexible
legislation, which could include this
new material. The majority of ques-
tions on this subject continue to be un-
answered, raising ethical and moral di-
lemmas that are not easily resolved,
just as they raise philosophical and in-
tuitive considerations.2
UNESCO
UNESCO is one of the first inter-
national Organizations to have tried
working with bioethics. The Universal
Declaration of the Human Genome and
Human Rights, adopted unanimously
and applauded at the General Confer-
ence of UNESCO in November, 1997
is one of the major achievements of
such efforts. The Declaration was en-
dorsed by the United Nations General
Assembly in December, 1998, within
the context of the 50th anniversary cel-
ebration of the Universal Declaration
of Human Rights.
Drawn up by the International Bio-
ethics Committee of UNESCO
(founded in 1993), the Universal Dec-
laration of the Human Genome and Hu-
man Rights is the first international stan-
dard in the field of bioethics. Article 1
states that the human genome is the “in-
heritance of humanity.” The idea is to
emphasize the fact that research on the
human genome and the applications that
could stem from such research is the re-
sponsibility of humanity as a whole, in
the interests of present and future gen-
erations. The expression “the shared in-
heritance of humanity,” which was ini-
tially proposed, was subsequently
changed to “the inheritance of human-
ity,” so as to avoid any interpretation
that could possibly leave the human ge-
nome open to collective, individual, or
private appropriation.
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This obviously leads to ruling out
human genome patentability. Article 4
of the Declaration confirms this asser-
tion, by stating:
“The human genome in its natural
state shall not give rise to financial
gains.”
UNESCO, in accordance with its
calling to further the sharing of knowl-
edge, feels that the fact of knowing of
a human gene or its partial sequences
in its natural state cannot be the object
of intellectual property rights, and that
this knowledge must be freely acces-
sible to all those involved in research
world-wide. This does not rule out the
fact that the results of research may be
covered by intellectual property rights.
The Declaration also contains pro-
visions for scientific cooperation. Un-
der Article 18, member states are urged
to make every effort “to continue fos-
tering the international dissemination
of scientific knowledge concerning the
human genome, human diversity, and
genetic research (...) particularly be-
tween industrialized and developing
countries.” Article 19 invites member
states to take measures enabling “de-
veloping countries to benefit from the
achievements of scientific and techno-
logical research, and foster the free ex-
change of scientific knowledge and in-
formation in the areas of biology, ge-
netics and medicine” 3.
BRAZILIAN LEGISLATION
Section III – Of the inventions and
utility models that are non-patentable.
Art .18 What are not non-patent-
able:
I - all that is contrary to ethics, to
good customs and to security, public
order and health;
II - the substances, materials, mix-
tures, elements or products of any kind,
as well as the modification of their physi-
cal-chemical properties, and the respec-
tive processes for obtaining or modify-
ing them, when they are the results of
atomic nucleus transformation; and
III - all or part of living beings,
with the exception of genetically modi-
fied micro-organisms which fulfill the
three requisites for patentability – nov-
elty, creative activity and industrial ap-
plication - foreseen in art 8 and, which
are not mere discoveries.
 Singular paragraph: In accordance
with this law, genetically modified mi-
cro-organisms are organisms, except all
or part of plants or animals which ex-
press, through direct human interven-
tion in their genetic composition, a
characteristic not normally attainable
by the species in natural conditions4.
In the face of the incipient nature
of this research - Brazil has a modest
role, giving its contribution through the
Human Cancer Genome Project and by
the sequencing of a farm pest (Xylella
fastidiosa) - Brazilian law is poor in
this sense. Apart from this consider-
ation, Brazilian law is very restrictive.
For this reason, efforts by bioethicists,
legislators, and jurists have become
imperative. In this new era, the inad-
equacy and restriction of our legisla-
tion calls for the Brazilian Society of
Bioethics and the National Technical
Commission for Bio-security
(CTNBio)5 to work together in order to
monitor and apply ethical values, while
at the same time taking care not to cre-
ate obstacles with respect to the growth
of what we believe could contribute to
the development of the “quality of life”
on the planet.
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O avanço científico e tecnológico
nunca será anti-ético. Ao menos, en-
quanto considerarmos que “a busca de
novos caminhos” para o Homem, sig-
nifica condição melhor dele ter autono-
mia. Tudo o que se vem descobrindo
nas últimas décadas, desde o controle
da natalidade, até a probabilidade de se
realizar brevemente a clonagem de se-
res humanos, incluindo-se entre estas
últimas descobertas a extraordinária
possibilidade de se intervir no próprio
gene humano, representa a condição de
assumirmos nós mesmos o controle
daquilo que até então desconhecíamos,
e, assim, podermos alcançar uma qua-
lidade de vida melhor.
Quanto ao ideal, este inquestiona-
velmente é o de estarem, os conheci-
mentos que podem alterar substancial-
mente nossa vida no planeta, ao alcan-
ce pleno da sociedade mundial, caben-
do a ela o monitoramento da aplicação
desses conhecimentos.
O presente artigo discute a ética e
o patenteamento do genoma humano,
os argumentos a favor e contra o
patenteamento de genes, patentes e
pesquisas com embriões humanos, as-
pectos legais e propriedade intelectual
no campo do genoma humano.
DESCRITORES: Bioética.
Genoma. Direitos Humanos. Paten-
teamento. Propriedade Intelectual.
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